Organization
Emory University Hospital
13 abstracts
Abstract
SACI-IO HR+: A randomized phase II trial of sacituzumab govitecan with or without pembrolizumab in patients with metastatic hormone receptor-positive/HER2-negative breast cancer.Org: Dana-Farber Cancer Institute, University of Chicago Medicine, UNC Lineberger Comprehensive Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Emory University Hospital,
Abstract
Association of combination tumor texture and vessel tortuosity with progression free survival across PD-L1 subgroups in durvalumab treated non-small cell lung cancer (NSCLC): Blinded validation results from CP1108.Org: Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory University, Emory University Hospital, University Hospitals Cleveland Medical Center, New York University School of Medicine, Laura and Isaac Perlmutter Cancer Center,
Abstract
Is a completion axillary dissection in patients with early breast cancer with a positive sentinel node necessary? An NCDB-based trial emulation of ACOSOG Z0011.Org: Department of Biostatistics and Bioinformatics, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan, Emory University, Atlanta, GA, USA, Emory University Hospital, Winship Cancer Institute of Emory University, Department of Radiation Oncology, Sichuan Cancer Hospital & Institute, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China,
Abstract
XMT-1660: A phase 1b trial of a B7-H4 targeted antibody drug conjugate (ADC) in breast, endometrial, and ovarian cancers.Org: Sarah Cannon Research Institute/Tennessee Oncology, Tennessee Oncology, PLLC, Summit Cancer Centers, Spokane Valley, WA, Virginia Cancer Specialists, Perlmutter Cancer Center at NYU Langone Health Medical Center,
Abstract
CT radiomic signature to predict overall survival and chemotherapy benefit in stage I and II HPV-associated oropharyngeal carcinoma.Org: Emory University, Atlanta, GA, USA, Atlanta, GA, Cleveland Clinic Taussig Cancer Instititute, Cleveland, OH, Emory University Hospital,
Abstract
Health-related quality of life (HR-QOL) measures in renal cell carcinoma (RCC): Patient-reported relevance of items of the FKSI-19, EORTC QLQ-C30, and EQ-5D.Org: Oncoclinicas & Co - Medica Scientia Innovation Research (MEDSIR), Rio De Janeiro, Brazil, City of Hope Comprehensive Cancer Center, Centro de Cancer de Brasilia, Instituto Unity de Ensino e Pesquisa, Grupo Oncoclinicas,
Abstract
Use of machine learning derived features from CT and H&E whole-slide images to predict overall survival in head and neck squamous cell carcinoma.Org: Emory University, Atlanta, GA, USA, Therapanacea, Cleveland Clinic Taussig Cancer Instititute, Emory University Hospital, Case Western Reserve University School of Medicine,
Abstract
Presence of hyperdiploidy and history of tobacco use in African American patients with SMM.Org: Emory University, Atlanta, GA, USA, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, Emory University Hospital, Winship Cancer Center of Emory University,
Abstract
Efficacy and safety of elranatamab by age and frailty in patients (pts) with relapsed/refractory multiple (RRMM): A subgroup analysis from MagnetisMM-3.Org: Massachusetts General Hospital Cancer Center, Surgical Oncology, Boston, MA, Harvard Medical School, CHU de Poitiers, Hôpital de la Milétrie - Centre Hospitalier Universitaire de Poitiers, Pôle Régional de Cancérologie,
Abstract
Elranatamab, a B-cell maturation antigen (BCMA)-CD3 bispecific antibody, for patients (pts) with relapsed/refractory multiple myeloma (RRMM): Extended follow up and biweekly administration from the MagnetisMM-3 study.Org: Sorbonne University and Saint-Antoine Hospital, Hôpital Saint-Antoine, INSERM UMRs938, Holden Comprehensive Cancer Center, University of Iowa Hospitals & Clinics,
Abstract
Investigation into the immune microenvironment of gastroenteropancreatic high-grade neuroendocrine carcinoma.Org: Emory University, Atlanta, GA, USA, Emory University School of Medicine, Winship Cancer Institute of Emory University, Emory University Hospital, Emory Winship Cancer Institue,
Abstract
Patient understanding of immunotherapy and its side effects for women with triple negative breast cancer.Org: Emory University Hospital, Department of Biostatistics & Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, GA, USA, Department of Biostatistics and Bioinformatics, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan,
Abstract
Genetic counseling referral frequency and attrition for newly diagnosed epithelial ovarian cancer at Grady Memorial Hospital from 2012-2022.Org: Emory University Hospital, Winship Cancer Center of Emory University, Emory University School of Medicine, Grady Memorial Hospital,